Lv3
318 积分 2025-06-20 加入
CAR T-cells in multiple myeloma: the race to the start line
2个月前
已完结
Long-Term Follow-Up of Combination of B-Cell Maturation Antigen and CD19 Chimeric Antigen Receptor T Cells in Multiple Myeloma
2个月前
已完结
A combination of humanised anti-CD19 and anti-BCMA CAR T cells in patients with relapsed or refractory multiple myeloma: a single-arm, phase 2 trial
2个月前
已完结
Dual-targeting CAR-T cells with optimal co-stimulation and metabolic fitness enhance antitumor activity and prevent escape in solid tumors
2个月前
已完结
CAR T cell persistence in cancer
2个月前
已完结
Optimization Strategies in CAR T-cell Therapy
2个月前
已完结
Efficacy and Safety of TLR2 Co-Stimulated CAR T Cells in CD19-Positive Lymphoid Malignancies with Central Nervous System Involvement
2个月前
已完结
Overcoming T cell tolerance to tumor self-antigens through catch-bond engineering
3个月前
已完结
9G4+ Autoantibodies Are an Important Source of Apoptotic Cell Reactivity Associated With High Levels of Disease Activity in Systemic Lupus Erythematosus
3个月前
已完结
Targeting autoreactive B cells in SLE with anti-9G4 synthetic immune receptor T cells
3个月前
已完结
皖公网安备34019202002308
